Contract Research Organization (CRO) Market Size & Share, by Type (Early Phase, Consulting, Clinical Lab); Therapeutic Area (Immunology, Hematology, Oncology, Infectious Disease, Neurology, Cell & Gene Therapy, Vaccines); End-user (Pharma & Biopharma Companies, Academic Institutes, Medical Device Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4754
  • Published Date: Mar 28, 2023
  • Report Format: PDF, PPT

Companies Dominating the Contract Research Organization (CRO) Landscape

top-features-companies
    • IQVIA, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ICON plc
    • Abbott Laboratories
    • Apple, Inc.
    • Dexcom, Inc.
    • Fitbit, Inc.
    • F. Hoffmann-La-Roche Ltd.
    • Johnson & Johnson
    • Medtronic plc
    • NeuroMetric, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • IQVIA, Inc. announced the partnership with Argenx SR by signing a multi-year contract. It covers the creation of additional indications for VYVGARTTM, an FDA-approved neonatal Fc receptor blocker for the treatment of generalized myasthenia gravis in individuals over the age of 18.

  • ICON plc signed a concluding agreement to completely acquire PRA Health Sciences, Inc. The buy-out has been finalized in stock and cash transaction of USD 12 Billion. With this acquisition, the two companies aim to execute high-quality and effectively clinical trials from Phase 1 through post-approval studies.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4754
  • Published Date: Mar 28, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of chronic illness, the rising popularity of advanced medicinal therapies, and higher investment for carrying out research and development of various drugs and therapies are the major factors driving the market growth.

The market size of contract research organization (CRO) is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.

The risk of violating the regulation, and concerns associated with outsourcing medical devices are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are ICON plc, Abbott Laboratories, Apple, Inc., Dexcom, Inc., Fitbit, Inc., F. Hoffmann-La-Roche Ltd., Johnson & Johnson, Medtronic plc, NeuroMetric, Inc., and IQVIA, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, therapeutic area, end user, and by region.

The oncology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying